Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria
2011

Genetic Diagnosis of Primary Hyperoxaluria in Tunisian Patients

Sample size: 57 publication Evidence: moderate

Author Information

Author(s): Mbarek Ibtihel Benhaj, Abroug Saoussen, Omezzine Asma, Zellama Dorsaf, Achour Abdellatif, Harbi Abdelaziz, Bouslama Ali

Primary Institution: Sahloul University Hospital, Sousse, Tunisia

Hypothesis

The study aimed to analyze the prevalence of specific AGXT gene mutations causing primary hyperoxaluria (PH1) in Tunisian patients.

Conclusion

The study found that limited mutation analysis can identify genetic causes of PH1 in 28% of patients, aiding in diagnosis and genetic counseling.

Supporting Evidence

  • I244T and 33_34insC mutations were identified in 42% of patients with detected mutations.
  • The study reported a high consanguinity rate of 75% among families.
  • The majority of patients presented with advanced renal disease at diagnosis.

Takeaway

This study looked at a rare disease called primary hyperoxaluria and found that certain gene changes are common in Tunisian patients, helping doctors diagnose and treat them better.

Methodology

Polymerase chain reaction and restriction fragment length polymorphism were used to detect mutations in the AGXT gene in DNA samples from patients.

Limitations

The study was limited by the number of tested mutations and the inability to evaluate the frequency of other potential mutations in Tunisia.

Participant Demographics

The study included 57 patients from 40 families, with a mean age of 16 years and a sex ratio of 1.09 (24 males and 22 females).

Digital Object Identifier (DOI)

10.1186/1471-2369-12-25

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication